Signed in · PRO

Guidance history, every release

Amgen (AMGN) · 8 releases, Oct 30, 2024 to Aug 4, 2026 · rows are metrics, columns are releases

Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing

Metric	Oct 30, 2024 FY24 Q3	Feb 4, 2025 FY24 Q4	May 1, 2025 FY25 Q1	Aug 5, 2025 FY25 Q2	Nov 4, 2025 FY25 Q3	Feb 3, 2026 FY25 Q4	Apr 30, 2026 FY26 Q1	Aug 4, 2026 FY26 Q2
For FY2026
Total revenues	—	—	—	—	—	New“$37.0 billion to $38.4 billion”	Raised“$37.1 billion to $38.5 billion”	Raised“$38.2 billion to $39.4 billion”
EPS (GAAP basis)	—	—	—	—	—	New“$15.45 to $16.94”	—	Raised“$15.80 to $17.08”
EPS (non-GAAP basis)	—	—	—	—	—	New“$21.60 to $23.00”	—	Raised“$22.30 to $23.50”
GAAP diluted EPS	—	—	—	—	—	—	New“$ 15.62 — $ 17.10”	—
Non-GAAP diluted EPS	—	—	—	—	—	—	New“$ 21.70 — $ 23.10”	—
Capital expenditures	—	—	—	—	—	New“approximately $2.6 billion”	Reiterated“approximately $2.6 billion”	Reiterated“approximately $2.6 billion”
GAAP tax rate	—	—	—	—	—	—	New“14.5 % — 16.0 %”	—
Net selling price	—	—	—	—	—	New“decline by roughly mid single-digits”	—	—
Non-GAAP tax rate	—	—	—	—	—	—	New“15.0 % — 16.5 %”	—
Share repurchases	—	—	—	—	—	New“not to exceed $3 billion”	Reiterated“not to exceed $3.0 billion”	Reiterated“not to exceed $3.0 billion”
Tax rate (GAAP basis)	—	—	—	—	—	New“15.5% to 17.0%”	—	Lowered“14.5% to 16.0%”
Tax rate (non-GAAP basis)	—	—	—	—	—	New“16.0% to 17.5%”	—	Lowered“15.0% to 16.5%”
For FY2025
Total revenues	—	New“$34.3 billion to $35.7 billion”	Reiterated“$34.3 billion to $35.7 billion”	Raised“$35.0 billion to $36.0 billion”	Raised“$35.8 billion to $36.6 billion”	—	—	—
EPS (GAAP basis)	—	New“$10.89 to $12.14”	—	Narrowed“$10.97 to $12.11”	Raised“$13.76 to $14.60”	—	—	—
EPS (non-GAAP basis)	—	New“$20.00 to $21.20”	—	Raised“$20.20 to $21.30”	Raised“$20.60 to $21.40”	—	—	—
GAAP diluted EPS	—	—	New“$ 12.21 — $ 13.46”	—	—	—	—	—
Non-GAAP diluted EPS	—	—	New“$ 20.00 — $ 21.20”	—	—	—	—	—
Capital expenditures	—	New“approximately $2.3 billion”	Reiterated“approximately $2.3 billion”	Reiterated“approximately $2.3 billion”	Lowered“$2.2 billion to $2.3 billion”	—	—	—
Dividend	—	—	—	—	New“$2.38 per share”	—	—	—
Dividend	—	—	—	New“$2.38 per share”	—	—	—	—
Dividend	—	—	New“$2.38”	—	—	—	—	—
GAAP tax rate	—	—	New“11.0 % — 12.5 %”	—	—	—	—	—
Non-GAAP tax rate	—	—	New“14.5 % — 16.0 %”	—	—	—	—	—
Share repurchases	—	New“not to exceed $500 million”	Reiterated“not to exceed $500 million”	Reiterated“not to exceed $500 million”	Reiterated“not to exceed $500 million”	—	—	—
Tax rate (GAAP basis)	—	New“11.0% to 12.5%”	—	Reiterated“11.0% to 12.5%”	Raised“14.5% to 16.0%”	—	—	—
Tax rate (non-GAAP basis)	—	New“15.0% to 16.0%”	—	Widened“14.5% to 16.0%”	Raised“15.0% to 16.5%”	—	—	—
For FY2024
Total revenues	New“$33.0 billion to $33.8 billion”	—	—	—	—	—	—	—
EPS (GAAP basis)	New“$8.71 to $9.56”	—	—	—	—	—	—	—
EPS (non-GAAP basis)	New“$19.20 to $20.00”	—	—	—	—	—	—	—
Capital expenditures	New“approximately $1.3 billion”	—	—	—	—	—	—	—
Dividend	—	New“$2.25 per share”	—	—	—	—	—	—
Dividend	New“$2.25 per share”	—	—	—	—	—	—	—
Share repurchases	New“not to exceed $500 million”	—	—	—	—	—	—	—
Tax rate (GAAP basis)	New“9.0% to 10.5%”	—	—	—	—	—	—	—
Tax rate (non-GAAP basis)	New“14.0% to 15.0%”	—	—	—	—	—	—	—

Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.